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Abstract
Salmonella enterica is a species of bacteria that is a major cause of enteritis across the globe, while certain serovars cause
typhoid, a more serious disease associated with a significant mortality rate. Type III secreted effectors are major contributors
to the pathogenesis of Salmonella infections. Genes encoding effectors are acquired via horizontal gene transfer, and a
subset are encoded within active phage lysogens. Because the acquisition of effectors is in flux, the complement of effectors
possessed by various Salmonella strains frequently differs. By comparing the genome sequences of S. enterica serovar
Typhimurium strain SL1344 with LT2, we identified a gene with significant similarity to SseK/NleB type III secreted effector
proteins within a phage ST64B lysogen that is absent from LT2. We have named this gene sseK3. SseK3 was co-regulated
with the SPI-2 type III secretion system in vitro and inside host cells, and was also injected into infected host cells. While no
role for SseK3 in virulence could be identified, a role for the other family members in murine typhoid was found. SseK3 and
other phage-encoded effectors were found to have a significant but sparse distribution in the available Salmonella genome
sequences, indicating the potential for more uncharacterised effectors to be present in less studied serovars. These phage-
encoded effectors may be principle subjects of contemporary selective processes shaping Salmonella-host interactions.
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Introduction
Salmonella enterica is a Gram-negative intracellular bacterial
pathogen of animals. Salmonella is a major cause of enteritis across
the world and is also the cause of typhoid, a frequently fatal disease
prevalent in developing nations. The pathogenesis of Salmonella
induced enteritis involves penetration of the intestinal epithelium
and, through interactions with epithelial and immune cells,
Salmonella induces significant inflammation in the intestine
resulting in diarrhoea [1]. During typhoid, following penetration
of the intestinal epithelium Salmonella enters phagocytic cells and is
transported to the mesenteric lymph nodes and to the liver and
spleen [1]. At these sites Salmonella resides primarily within
macrophages and initiates substantial inflammation [2,3].
The principle factors allowing Salmonella to penetrate the
intestinal epithelium and replicate within phagocytes of the host
are ‘effectors’, proteins that are injected into infected host cells by
type III secretion systems (T3SSs) [4]. Salmonella encodes two
separate T3SSs, each of which is generally considered to function
at distinct stages of pathogenesis. T3SS-1 and T3SS-2 (encoded by
Salmonella pathogenicity islands 1 and 2, respectively) translocate
effectors that collectively mediate penetration of the intestinal
epithelium (T3SS-1) [5] or replication within phagocytic cells
(T3SS-2) [6,7]. In the host cell, effectors are hypothesized to
interact with specific host molecules, which are subverted in order
to benefit the infecting Salmonella [1].
While Salmonella encodes two separate T3SSs, each of which was
acquired via horizontal gene transfer, the genes encoding effectors
are typically encoded at unlinked genomic sites and were likely
horizontally acquired separately from SPI1 and 2. Commensurate
with the theme of frequent horizontal acquisition of effector-
encoding genes, different strains of Salmonella commonly possess
different arsenals of effectors. Even the closely related S. enterica
serovar Typhimurium (S. typhimurium) strains SL1344 and 14028,
which are the most commonly used model strains used in
pathogenesis studies, possess different complements of effectors.
SL1344 possesses sopE whilst 14028 does not, and vice versa for
sspH1 [8]. Each of these effectors is encoded on a separate
prophage (SopEQ and Gifsy-3, respectively) [8,9].
To date, the only published and annotated genome sequence of a
S. typhimurium strain is that of LT2, an avirulent strain that serves
primarily as a model for bacterial and phage genetics. The genome
sequence of the virulent strain SL1344 has recently been completed
and is currently being annotated at the Wellcome Trust Sanger
Institute. Relying on the hypothesis that the genetic complement of
effectors frequently varies between strains, we aimed to identify
novel effectors based on their similarity to known effectors by
comparing the unannotated genome sequence of SL1344 to the
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SseK/NleB family of effectors, which we have termed SseK3.
Results
Comparison of the SL1344 and LT2 genomes
Regions of the SL1344 genome that are not present in the
genome of LT2 were identified by comparison using MEGA-
BLAST and ARTEMIS COMPARISON TOOL as described in
the materials and methods. This identified nine regions in the
SL1344 chromosome that were not present in the LT2
chromosome, whereas the virulence plasmids were not signifi-
cantly different. The nine unique regions of the SL1344
chromosome encoded 111 open reading frames (ORFs) from the
preliminary annotation provided by the Sanger Institute, plus 6
additional ORFs we annotated ourselves. We performed BLAST
searches of the nonredundant amino acid sequence database using
the deduced amino acid sequence of each unique ORF as a query.
We then analysed the output from each search with a focus on
identifying unique ORFs with significant similarity to effectors.
This analysis identified two genes with significant similarity to
effectors. One of these, sopE, is known to be present in SL1344 [9]
and absent from LT2 [10]. sopE is carried on a phage SopEQ
lysogen in SL1344 at the same locus as a phage Fels-2 lysogen in
LT2. The phages SopEQ and Fels-2 share a high degree of identity
over most of their genomes, with numerous segments that appear
to have been exchanged relative to each other that are represented
in figure 1A [11]. One of these segments, unique to SL1344,
encodes sopE.
The second gene encodes a protein that showed 75% identity
to the effector SseK2 [12] from LT2 in a BLAST search. This
gene corresponds to ORF sb26 encoded within a phage ST64B
[13] lysogen carried by SL1344 [8], which is absent from LT2
[10]. Unlike the situation for sopE, where SL1344 and LT2
harbour distinct, but closely related lysogens at equivalent loci,
the ST64B lysogen occupies an attachment site that is
unoccupied in LT2 (Fig. 1B). As can be seen in the amino acid
sequence alignment of the members of the SseK/NleB family of
effectors, ORF sb26 clearly encodes for a protein that is highly
related to this family of effectors (Fig. 1C). ORF sb26 is clearly
distinct from the SL1344 orthologues of sseK1 and sseK2 from
LT2, hence we propose that the ORF sb26 constitutes the third
SseK/NleB family member identified within Salmonella and that it
be renamed sseK3.
Figure 1. Phage encoded genomic differences between S. typhimurium SL1344 and LT2. A & B. Screenshots from ARTEMIS COMPARISON
TOOL showing (A) differences in the SopEQ/Fels-2 region and (B) the ST64B insertion in SL1344 relative to LT2. The SL1344 sequence is shown on top
and LT2 at the bottom. The red regions indicate alignment between the two genome sequences and the white regions indicate gaps in the
alignment. C. Alignment of the amino acid sequences of SseK3 and other SseK/NleB family members. Residues conserved in all five proteins are
shaded in maroon, those conserved in three or four proteins are shaded in cyan. SseK1 and 2 sequences are from LT2 and NleB1 and 2 are from E. coli
strain EDL933.
doi:10.1371/journal.pone.0017824.g001
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Regulation and expression of effectors is typically co-ordinated
by pathogencity island encoded transcription factors that control
expression of the respective T3SS. During culture in vitro,
logarithmic phase growth in LB medium is most commonly used
to induce expression of the SPI1 regulon, whereas logarithmic
phase growth in low phosphate, low magnesium minimal (LPM)
medium induces expression of the SPI2 regulon [14–16]. More
recently, stationary phase growth in LB medium has been shown
to also induce expression of the SPI2 regulon [17]. To search for
any correlation of the expression pattern of SseK3 with the SPI1
and SPI2 regulons, a wild type Salmonella strain expressing HA
epitope tagged SseK3 (SseK3-HA) from its native upstream region
on a low copy number plasmid was cultured under the three
culture conditions described above. Western blotting of whole cell
lysates from these cultures and probing with anti-HA antibodies
indicated that SseK3 is expressed in LPM medium and during
stationary phase, but not logarithmic phase in LB medium (Fig. 2).
Levels of the SPI2 protein, SseB, in the same samples showed a
similar expression pattern as SseK3 (Fig. 2). As a further control,
levels of the constitutively expressed protein, DnaK, were
unaffected by growth condition (Fig. 2). Additionally, when E.
coli DH5a transformed with the same SseK3 expression plasmid
was subjected to the same experimental conditions, SseK3
expression could not be detected. This suggests that expression
of SseK3 requires regulatory factors that are present in Salmonella
and absent from E. coli.
Key transcription factors controlling expression of SPI1 and
SPI2 genes are HilA and SsrB, respectively [6,14,16,18].
Expression of SseK3 from hilA and ssrB Salmonella transformed
with the same plasmid and under the same culture conditions as
above was also analysed by western blotting. Mutation of ssrB
completely abrogated expression of SseK3, whereas mutation of
hilA had little affect (Fig. 2). This was paralleled in the SPI2 control
protein, SseB, and neither mutation had any affect on expression
of the constitutive control protein, DnaK (Fig. 2). These findings
are consistent with SseK3 belonging to the SsrB (SPI2) regulon
and not the HilA (SPI1) regulon.
A prominent feature of the SsrB regulon is induction of
expression following entry of Salmonella into host cells [6]. If SseK3
belongs to the SsrB regulon its expression should also be induced
within host cells. To test this hypothesis bone-marrow derived
macrophages were infected with Salmonella transformed with a
plasmid containing a transcriptional fusion of gfp to the sseK3
upstream region, and at 0.5 and 8 h post-infection the Salmonella
fluorescence intensity was quantified by flow cytometry. Tran-
scription from the sseK3 upstream region was induced in host cells,
with higher levels observed at 8 h post-infection than 0.5 h
(Fig. 3A). As a control, an ssrB strain transformed with the same
plasmid showed little induction of SseK3 expression following
uptake into host cells (Fig. 3A). As an alternative approach, and to
show expression at the protein level in host cells, HeLa cells were
infected for 2, 6, 12 and 21 h with wild type or ssrB Salmonella
transformed with the SseK3-HA expression plasmid described
above. Lysates from these infected cells, normalised to the number
of Salmonella, were western blotted and probed for SseK3-HA
expression, which could be observed to increase with time in the
wild type, but not the ssrB strain (Fig. 3B). PipB is a SPI2 effector
that belongs to the SsrB regulon [6,19], and a control infection
with wild type transformed with a PipB-HA expression plasmid
also showed expression levels that increased with time during
intracellular infection (Fig. 3B). These results show that SseK3 is
expressed inside host cells in an SsrB dependent manner, and
collectively demonstrate that SseK3 belongs to the SsrB regulon.
SseK3 secretion and translocation into host cells
Secretion of most SPI2 effectors can be induced during in vitro
culture in LPM medium at low pH (pH 5.8). Under such artificial
conditions, T3SSs secrete distinct classes of substrates into the
extracellular medium, the most abundant of which are effectors
and translocators. It is hypothesised that secretion of these
substrate classes is, at least in part, controlled by an InvE family
member in each T3SS [20,21], such that in an invE strain effectors
are hypersecreted and translocators are not secreted [20]. The
SPI2 InvE family member is SsaL, which when knocked out results
in a lack of translocator secretion and hypersecretion of effectors
into culture supernatants [22]. To investigate whether SseK3 is
secreted in a manner consistent with being an effector, wild type,
ssaR (T3SS-2 null) and ssaL Salmonella transformed with the HA
tagged SseK3 expression plasmid were grown under secretion
inducing conditions and culture supernatant proteins were
analysed by western blotting. SseK3 was found in supernatants
only from ssaL strain cultures (Fig. 4). Also, the constitutively
expressed cytoplasmic control protein, DnaK, was detected in
equal abundance and only associated with the bacterial pellet
(Fig. 4). The lack of detectable secretion from wild type Salmonella is
inconsistent with SseK3 being a secreted effector, although the low
expression level of SseK3 may have precluded its detection. On
the other hand, the increased level of SseK3 secretion from ssaL
Salmonella, together with the demonstrated homology to SseK/
NleB effectors (Fig. 1C) is consistent with SseK3 being a effector
substrate of the T3SS-2 system.
Ultimately, the definitive feature of an effector is that it is
translocated into host cells. To test this, host cells infected for 18 h
with wild type or ssaR Salmonella transformed with the HA tagged
SseK3 expression plasmid were subjected to fractionation as
described in the Materials and Methods. This procedure fractionates
the infected host cells into a low speed pellet fraction (P) containing
bacteria, unbroken cells, nuclei and large polymers, a high speed
pellet (M) containing host cell membranes and a supernatant
Figure 2. Expression of SseK3 in culture medium. Western blots
of whole bacterial cell lysates from the culture conditions and strain
genotypes indicated at the top of the figure were probed with the
antibodies indicated to the left of the respective panels. The anti-HA
panels show a cross-reacting band in each lane just below the SseK3
band. This cross-reacting band is lower in the E. coli lysates than the
Salmonella lysates. The arrow to the right of the a-HA panel indicates
the bands corresponding to SseK3-HA.
doi:10.1371/journal.pone.0017824.g002
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contamination between these fractions was demonstrated using
antibodies against calnexin (host cell membrane protein), b tubulin
(host cell cytosolic protein) and DnaK (Fig. 5). Both the M and C
fractions are free of infecting bacteria and any bacterial protein in
these fractions must have been transported from the bacteria into
the host cell. For instance, the SPI2 effector control, SifA, can
clearly be observed in the M fraction in cells infected with wild
type, but not the SPI2 null ssaR strain (Fig. 5), demonstrating that
SifA is translocated into host cells where it associates with host cell
membranes as previously shown [23,24]. SseK3 can be observed
in both the M and C fractions in wild type infected cells (Fig. 5),
demonstrating that it is delivered into host cells, consistent with
being an effector. However, SseK3 expression could not be
detected in the ssaR Salmonella infected cells and hence it cannot be
concluded that translocation of SseK3 into host cells is dependent
on T3SS-2.
The role of SseK effectors in Salmonella virulence
Previous work on SseK1 and 2 failed to find a role in virulence,
either in terms of replication of Salmonella inside host cells or
virulence in mice [12]. Considering that this could be due to
functional redundancy with SseK3, which was functional in the
strains tested by Kujat Choy et al. [12], we initially focussed our
efforts in studying a strain mutated for all three SseK family
members. Whilst we found no phenotype for the SseK family
during intracellular replication in RAW264.7 cells (data not
shown) we did identify a statistically significant (P,0.0001)
attenuation at 72 h post-inoculation using competitive index
infections of mice. (Fig. 6). This indicated that the SseK family
of effectors do contribute to virulence. However, whilst a role in
virulence for SseK1 and 2 could not be found in a previous study,
Figure 3. Expression of SseK3 in host cells. A. Graphs showing GFP fluorescence intensity of intracellular wild-type or ssrB Salmonella containing
an sseK3 promoter GFP fusion plasmid. Cells were infected for 0.5 h and 8 h before being processed for flow cytometry. B. Western blots of infected
HeLa cell lysates made at the indicated times post-infection (hours PI), with the indicated strains transformed with plasmids encoding the indicated
effector fused to tandem HA epitopes. The western blots were probed for the HA epitope and DnaK as a loading control.
doi:10.1371/journal.pone.0017824.g003
Figure 4. Secretion of SseK3. Western blots of concentrated culture
supernatant proteins and whole Salmonella cell lysates (pellet) from
strains genotypes indicated at the top of the figure were probed with
the antibodies indicated to the left of the figure. The arrow to the right
of the a-HA panel indicates the bands corresponding to SseK3-HA.
doi:10.1371/journal.pone.0017824.g004
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because of it’s lack of sensitivity and quantitation. Therefore we
hesitated to conclude that SseK3 was responsible for the virulence
defect, and investigated the role of SseK3 further. Competitive
index experiments comparing the virulence of an sseK3 strain to wt
indicated no role SseK3 in virulence (Fig. 6), suggesting that the
results we had obtained with the sseK123 triple mutant were most
likely due to SseK1 and/or 2. We confirmed this hypothesis by
comparing an sseK12 double mutant to wt in competitive index
experiments and found a statistically significant degree of
attenuation (P=0.0007), similar in magnitude to that of the
sseK123 triple mutant. So it is clear that a minor role in virulence
for the SseK family exists, it seems unlikely that SseK3 itself plays a
significant part.
Discussion
Above we identified and described a member of the SseK/NleB
family of effectors that was encoded in phage ST64B by genome
comparison between the virulent SL1344 strain of S. typhimurium
and the laboratory strain LT2. This new member, SseK3, has a
somewhat limited distribution in the available Salmonella genomes
(Table 1), consistent with it being encoded on a temperate phage.
In contrast, SseK1 and SseK2, which are not phage-encoded, are
present in most available Salmonella genome sequences.
SseK3 expression was induced, albeit to a relatively low level, in
SPI2 inducing minimal medium and inside host cells, whereas no
expression was observed under SPI1 inducing conditions. This
expression profile led us to show that SseK3 is translocated into
host cells following intracellular growth of Salmonella. However, the
relatively low level of SseK3 expression combined with the low
intracellular growth rate of T3SS-2 null Salmonella precluded
effective assessment of the role of T3SS-2 in translocation of
SseK3. Similarly, secretion of SseK3 into culture supernatants
could be detected in the hypersecreting ssaL strain [22] but not the
wild type strain, again possibly due to relatively low levels of
expression. The phenotype of the ssaL strain, and the demon-
strated role of SsaL in substrate recognition for T3SS-2 secretion
[22] do provide some support the hypothesis that SseK3 is a
T3SS-2 translocated effector. Quantitative virulence experiments
in mice indicated no role for SseK3 in virulence, though, contrary
Figure 6. The role SseK effector in virulence. Competitive indices
were determined 3 days following oral inoculation of 129/svImJ mice
infected with an equal mixture of the indicated 2 strains. Values from
spleen and liver for individual mice are shown as diamonds and circles
respectively, and the mean is shown as a horizontal bar.
doi:10.1371/journal.pone.0017824.g006
Table 1. Strain distribution of phage encoded effectors of
Salmonella.
Serotype (strain) SseK3 SopE SspH1 GogB SseI
4,[5],12:i:- (CVM23701) + 22 ++
Agona (SL483) 22 222
Choleraesuis (SC-B67) 22 2++
Dublin (CT_02021853) ++ 22+
Enteritidis (PT4) ++ 22+
Gallinarum (287/91) 2 + 222
Hadar 2 + 222
Heidelberg (SL476) 2 + 222
Heidelberg (SL486) 2 + 222
Infantis 22 222
Javiana (GA_MM04042433) 2 ++ 22
Kentucky (CDC 191) 22 222
Kentucky (CVM29188) 22 222
Newport (SL254) 22 2++
Newport (SL317) 22 +++
Paratyphi A (ATCC9150) 2 + 222
Saintpaul (SARA23) 22 + 22
Saintpaul (SARA29) 2 ++ 22
Schwarzengrund (CVM19633) 2 + 222
Schwarzengrund (SL480) 2 + 222
Typhi (CT18) 2 + 222
Typhi (Ty2) 2 + 222
Typhimurium (D23580) + 22 ++
Typhimurium (DT104) 22 2++
Typhimurium (DT2) + 22 ++
Typhimurium (LT2) 22 2++
Typhimurium (14028s) + 2 +++
Typhimurium (SL1344) ++ 2 ++
doi:10.1371/journal.pone.0017824.t001
Figure 5. Translocation of SseK3 into infected HeLa cells.
Western blots from fractionated, infected HeLa cells probed with the
antibodies indicated to the left of the figure. SseK3-HA and SifA-HA
indicated at the top of the figure refer to the HA-tagged protein
expressed in the respective strain, and under this, wt and ssaR refer to
the genotype of the respective strain. P, C and M refer to the fractions
collected from the infected cells as described in the text. The arrow to
the right of the a-HA panel indicates the bands corresponding to SseK3-
HA and SifA-HA (which are approximately the same MW).
doi:10.1371/journal.pone.0017824.g005
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and/or SseK2 in Salmonella virulence. On balance, we suggest that
SseK3 is an effector that is expressed in small quantities, has a
limited role in virulence, and remains to be defined in terms of its
secretion and phenotype.
The approach used to identify SseK3 focused on identifying
type III secreted effectors in strain SL1344 that are homologous to
other effectors and absent from strain LT2. This approach was
validated by identifying the effector SopE, and further describing
its genomic context in SL1344 relative to LT2. There are aspects
to this approach that, with modification, may lead to the
identification of more effectors. The criteria that genes must show
similarity to known effectors could be disregarded in order to
produce a longer list of low GC content genes to characterise,
some of which would be likely to encode novel effectors. Another
potential modification is to search for differences between more S.
typhimurium strains, which may harbour different complements of
effectors. Extending this analysis to different serovars within the
genus Salmonella is likely to provide and even more complete list of
Salmonella effectors. The larger number of horizontally acquired
genomic differences between serovars has previously been
identified and shown to encode functions involved in virulence
that remain otherwise uncharacterised [25].
The identification of a new effector in Salmonella raises the
possibility that more effectors remain to be identified. The role in
virulence played by the majority of effectors is minimal [26–29].
Similarly, most T3SS dependent phenotypes are not understood in
terms of the effectors involved, with invasion and intercellular
junction disruption being exceptions [30,31]. Hence it is clear that
our understanding of effector repertoire and function is far from
complete. In considering these points together with the fact that
attaching and effacing pathogens employ one T3SS to translocate
up to 49 effectors in order to parasitise the gastrointestinal tract
[32], it seems possible that Salmonella, using two T3SSs to parasitise
the gastrointestinal tract and systemic sites, will encode numerous
effectors in addition to the 28 described thus far. Characterisation
of these is necessary to understand the pathogenesis of Salmonella
infection.
The identification of SseK3 brings the number of phage-
encoded effectors in SL1344 up to four (SopE, SseI and GogB)
[33], with SspH1 being found in S. typhiumurium strain 14028 [34].
Of these, GogB is expressed under a broad range of culture
conditions and when transferred into attaching and effacing E. coli
is expressed and secreted by the locus of enterocyte effacement
encoded T3SS [33]. SspH1 has a similar expression pattern to
GogB [16,34], and may also have the capacity to be secreted by
heterologous T3SSs. This is unlikely to be the case for SseK3 or
SseI, which appear to be specifically controlled by the SPI2-
encoded SsrA/B regulatory system. For instance SseK3 is not
expressed in E. coli DH5a (Fig. 2A).
The distribution of these phage-encoded effectors (Table 1) in
the available Salmonella genome sequences, determined as
described in the Materials and Methods, demonstrates the
plasticity of the effector complement across a range of strains.
The SseK3 encoding phage, ST64B, has also been shown to be
present in S. typhimurium strain 14028 and three strains of DT104
[8], yet it is not found in the DT104 strain whose genome has been
sequenced at the Sanger Institute. The variable presence or
absence of sseK3 in DT104, an S. typhimurium phage-type
considered to be essentially clonal [35], affirms that Salmonella-
host interactions are currently evolving. SseK3, GogB and SseI are
relatively more abundant in S. typhimurium than other serovars. On
the other hand, non-Typhimurium serovars seem to have a more
variable content of phage-encoded effectors, with SopE being
particularly prevalent. Reasons for this most likely reflect a
combination of the research bias towards S. typhimurium as well as
differences in virulence and host range among the surveyed
serovars. Horizontal acquisition of SopEQ phage has been shown
into increase virulence in a SopE dependent manner [36]. This,
together with recent data from an attaching and effacing
pathogen-host system demonstrating that virulence mediated by
type III effectors is positively selected [37], suggests that reshaping
effector content by horizontal gene transfer is linked to
evolutionary success. This, of course, is a challenging hypothesis
that remains to be tested, and also underscores the requirement to
study a larger sample of Salmonella serovars in order to identify all
effectors and understand their contributions to Salmonella virulence.
In summary, SseK3 is a phage-encoded effector that belongs to
the SPI2 regulon and is translocated into host cells. Together with
the other phage-encoded effectors of Salmonella, SseK3 likely
represents the cutting edge of the evolution of Salmonella-host
interactions.
Materials and Methods
Ethics statement
All experiments with animals were conducted according to
guidelines set by the Canadian Council on Animal Care. The
protocol (A09-0168) used during this work was approved by the
University of British Columbia’s Animal Care Committee.
Bioinformatics
The completed draft SL1344 chromosome sequence was
obtained from the Sanger Institute website (http://www.sanger.
ac.uk/Projects/Salmonella/SL1344.fasta) and the LT2 chromo-
some sequence was obtained from Genbank (accession #
AE006468). These sequences were compared using DOUBLE
ACT V2 (http://www.hpa-bioinfotools.org.uk/pise/double_act.
html#) with a cutoff score of 1000 to prepare a MEGABLAST
[38] output for analysis in ARTEMIS COMPARISON TOOL
V6 [39]. Using the preliminary gene prediction provided by the
Sanger Institute, we performed similarity searches of the deduced
amino acid sequences of predicted SL1344 genes not present in
LT2 using standalone BLAST V2.2.17 [40]. These searches were
performed with default settings against the non-redundant
database (nr) release from the 15th of October, 2007.
Amino acid sequence alignments were performed using
CLUSTAL W [41] and shaded and formatted using JALVIEW
v8.0 [42]. The survey of phage-encoded effectors among Salmonella
genomes was done by performing TBLASTX [40] searches of all
Salmonella genomes available at the NCBI genomic website (http://
www.ncbi.nlm.nih.gov/sutils/genom_table.cgi) and the Sanger In-
stitute website (http://www.sanger.ac.uk/cgi-bin/blast/submitblast/
salmonella).A strain was considered to havea copy of a given effector
if it had .90% identity over the full length of each sequence.
Bacterial strains, plasmids and culture
Escherichia coli strain DH5a was used for routine cloning and S.
typhimurium strain SL1344 and isogenic mutants thereof, referred to
by genotype, were used in this study. pSseK3-HA, the C-
terminally HA epitope tagged SseK3 expression plasmid, was
constructed by replacing the Sal I-Bgl II fragment containing gogB
and its upstream region of pWSK129-gogB-2HA [33] with a PCR
product containing sseK3 and its upstream region. The PCR
product was generated using primers sb26f2 (59-ATGGTCGAC-
CACAGCAATTAATCTTCTGC-39) and sb26r (59-ATGA-
GATCTTCTCCAGGAGCTGATAGT-39). To create an ampi-
cillin resistant version of this plasmid, termed pSseK3-HA.1, the Sal
Identification of a Phage-Encoded Effector
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sites of pWSK29 [43]. A plasmid expressing the sseK3 promoter
fused to gfp was constructed as per Coombes et al. [44] and psifA-
2HA and ppipB-2HA has been described previously [19,24].
Lysogeny broth [45,46] was used for the routine culture of all
bacteria. SPI1 induced, invasive Salmonella were cultured in LB as
previously described [47] and SPI2 induced Salmonella were grown
to logarithmic phase with shaking at 37uC in LPM medium [15].
Basic biochemistry techniques
For expression analysis of SseK3, bacteria from 1 ml of culture
grown in the indicated media were harvested by centrifugation at
16,000 g for 1 minute, the supernatant discarded and the pellet
dissolved in 200 ml of 1x Laemmli sample buffer [48]. For in vitro
secretion assays, culture supernatants were passed through a
0.2 mm syringe filter and the proteins precipitated by the addition
of trichloroacetic acid to a final concentration of 10% (v/v) in a
total volume of 2.0 ml. This was incubated on ice overnight and
the precipitated protein collected by centrifugation at 16,000 g for
1 h at 4uC. The supernatant was discarded and the pellet washed
in ice-cold 100% (v/v) acetone, followed by centrifugation at
16,000 g for 15 min at 4uC. The supernatant was discarded and
the pellet dissolved in 20 ml of 1x Laemmli sample buffer.
HeLa cells were infected as previously described [47] and
fractionation was performed according to the protocol described
by Gauthier et al. [49]. At 18 h postinfection, cells were collected
by scraping, lysed by passage through a 22-gauge needle and
fractionated into fraction P (a low speed pellet containing nuclei,
unbroken cells, bacteria and large polymers), fraction M (a high-
speed pellet containing host cell membranes) and fraction C (the
supernatant from a high speed centrifugation corresponding to
host cell cytosol). All fractions were dissolved in 1x Laemmli
sample buffer.
The mouse anti-HA antibody (Covance) was used at a dilution of
1:2000, the mouse anti-DnaK antibody (Stressgen) was used at a
dilution of 1:2000 and the anti-calnexin antibody (Stressgen) was used
at a dilution of 1:5000. The anti-b-tubulin antibody (E7) was used at a
dilution of 1:1000 and obtained from the Developmental Studies
Hybridoma Bank, developed under the auspices of the NICHD,
National Institutes of Health, and maintained by the University of
Iowa (Department of Biological Sciences, Ames, IA, USA).
Flow cytometry
Primary bone-marrow derived macrophages (BMDMs) were
derived as previously described [50]. At 30 min and 8 h
postinfection, supernatants were removed from macrophages were
washed three times in sterile PBS. Cells were scraped into 300 ml
of cold fluorescence-activated cell sorting (FACS) buffer containing
PBS, 2% FBS, 0.1% sodium azide, and 1 mM EDTA and
transferred into a 96-well round-bottomed tissue culture plate.
Plates were centrifuged for 3 min to pellet cells, and FACS buffer
was removed. RAW macrophages were incubated with 25 mlo f
biotinylated primary antibody F-480 (Serotec, Raleigh, NC) at a
dilution of 1:300 in FACS buffer for 30 min at 4uC. Cells were
washed twice in FACS buffer followed by incubation with
streptavidin-phytoerythrin (Cedarlane Laboratories Ltd., Hornby,
ON, Canada) at a dilution of 1:400 in FACS buffer for 30 min at
4uC. Cells were washed twice in FACS buffer and suspended in a
final volume of 150 ml of FACS buffer for flow cytometry analysis.
Samples were run on a FACSCalibur flow cytometer, with data for
10,000 events collected per sample using Cell Quest Pro software
(BD Biosciences, Mississauga, ON, Canada). Data were analyzed
using Flow Jo flow cytometry software (Tree Star Inc., Ashland,
OR).
Infection of mice
Mice were infected as previously described [44]. Briefly, mice
were inoculated orally with approximately 5610
7 of each strain,
one of which was marked with chloramphenicol resistance
(ushA::cat, which shows wild type virulence [14,51]). At 72 h
post-inoculation, mice were killed and the spleens and livers were
removed and homogenized. Organ homogenates were serially
diluted and plated on L-agar plates containing streptomycin for
determination of total numbers of Salmonella. Plates were replica
plated onto L-agar plates containing chloramphenicol to deter-
mine the proportion of ushA::cat Salmonella present in the
homogenate, allowing determination of competitive indices as
previously described [52,53]. Data was analyzed using a one-
sample t test against a theoretical mean of 1.
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